109 related articles for article (PubMed ID: 20429813)
21. Preparation and cytotoxicity of cisplatin-containing liposomes.
Carvalho Júnior AD; Vieira FP; Melo VJ; Lopes MT; Silveira JN; Ramaldes GA; Garnier-Suillerot A; Pereira-Maia EC; Oliveira MC
Braz J Med Biol Res; 2007 Aug; 40(8):1149-57. PubMed ID: 17665053
[TBL] [Abstract][Full Text] [Related]
22. Cholesterol-based anionic long-circulating cisplatin liposomes with reduced renal toxicity.
Kuang Y; Liu J; Liu Z; Zhuo R
Biomaterials; 2012 Feb; 33(5):1596-606. PubMed ID: 22079777
[TBL] [Abstract][Full Text] [Related]
23. Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: Effects of cryoprotectants on structure.
Stark B; Pabst G; Prassl R
Eur J Pharm Sci; 2010 Nov; 41(3-4):546-55. PubMed ID: 20800680
[TBL] [Abstract][Full Text] [Related]
24. The freeze-thawed and freeze-dried stability of cytarabine-encapsulated multivesicular liposomes.
Chen C; Han D; Zhang Y; Yuan Y; Tang X
Int J Pharm; 2010 Mar; 387(1-2):147-53. PubMed ID: 20005932
[TBL] [Abstract][Full Text] [Related]
25. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
Bhatia A; Kumar R; Katare OP
J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
[TBL] [Abstract][Full Text] [Related]
26. Polyethylenimine modified liposomes as potential carriers for antitumor drug delivery in vitro.
Sun X; Chen J; Chen H; Liang W
Pharmazie; 2012 May; 67(5):426-31. PubMed ID: 22764577
[TBL] [Abstract][Full Text] [Related]
27. Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method.
Qiu L; Jing N; Jin Y
Int J Pharm; 2008 Sep; 361(1-2):56-63. PubMed ID: 18573626
[TBL] [Abstract][Full Text] [Related]
28. [Studies on preparation and characteristics of cisplatin chitosan microspheres].
Wang YM; Shi TS; Pu YL; Zhu JG; Zhao YL
Yao Xue Xue Bao; 1996; 31(4):300-5. PubMed ID: 9208650
[TBL] [Abstract][Full Text] [Related]
29. Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro.
Krieger ML; Eckstein N; Schneider V; Koch M; Royer HD; Jaehde U; Bendas G
Int J Pharm; 2010 Apr; 389(1-2):10-7. PubMed ID: 20060458
[TBL] [Abstract][Full Text] [Related]
30. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
31. Lipophilic cisplatin analogues entrapped in liposomes: role of intraliposomal drug activation in biological activity.
Perez-Soler R; Khokhar AR
Cancer Res; 1992 Nov; 52(22):6341-7. PubMed ID: 1423280
[TBL] [Abstract][Full Text] [Related]
32. Long-Circulating and pH-Sensitive Liposome Preparation Trapping a Radiotracer for Inflammation Site Detection.
Mota LD; de Barros AL; Fuscaldi LL; de Oliveira MC; Cardoso VN
J Nanosci Nanotechnol; 2015 Jun; 15(6):4149-58. PubMed ID: 26369024
[TBL] [Abstract][Full Text] [Related]
33. Preclinical evaluation of a sterically stabilized liposome-encapsulated cisplatin in clinically normal cats.
Thamm DH; Vail DM
Am J Vet Res; 1998 Mar; 59(3):286-9. PubMed ID: 9522946
[TBL] [Abstract][Full Text] [Related]
34. Preparation and evaluation of a novel liposomal formulation of cisplatin.
Zhou X; Wang J; Wu J; Yang X; Yung BC; Lee LJ; Lee RJ
Eur J Pharm Sci; 2015 Jan; 66():90-5. PubMed ID: 25446511
[TBL] [Abstract][Full Text] [Related]
35. The antitumor effect of liposome-encapsulated cisplatin on rat osteosarcoma and its enhancement by caffeine.
Karita M; Tsuchiya H; Kawahara M; Kasaoka S; Tomita K
Anticancer Res; 2008; 28(3A):1449-57. PubMed ID: 18630498
[TBL] [Abstract][Full Text] [Related]
36. A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization.
Abdelwahed W; Degobert G; Fessi H
Int J Pharm; 2006 Feb; 309(1-2):178-88. PubMed ID: 16326053
[TBL] [Abstract][Full Text] [Related]
37. Preparation of plasmid DNA-containing liposomes using a high-pressure homogenization--extrusion technique.
Pupo E; Padrón A; Santana E; Sotolongo J; Quintana D; Dueñas S; Duarte C; de la Rosa MC; Hardy E
J Control Release; 2005 May; 104(2):379-96. PubMed ID: 15907587
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro cytotoxicity and in vivo intratumor drug accumulation against melanomas.
Hwang TL; Lee WR; Hua SC; Fang JY
J Dermatol Sci; 2007 Apr; 46(1):11-20. PubMed ID: 17267180
[TBL] [Abstract][Full Text] [Related]
39. [Assemble of magnetic nanoparticles into the structure of cisplatin liposome].
Wang L; Yang CQ; Wang J
Yao Xue Xue Bao; 2011 May; 46(5):592-8. PubMed ID: 21800550
[TBL] [Abstract][Full Text] [Related]
40. Freeze-dried nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution.
Ohshima H; Miyagishima A; Kurita T; Makino Y; Iwao Y; Sonobe T; Itai S
Int J Pharm; 2009 Jul; 377(1-2):180-4. PubMed ID: 19446623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
